Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Absorption of Anti-tuberculosis Drugs and Its Effect to Treatment Response in Gastrectomized Patients

NCT01364324 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT01364324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01364324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Absorption of Anti-tuberculosis Drugs and Its Effect to Treatment Response in Gastrectomized Patients
Lead sponsor
National Cancer Center, Korea
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
June 30, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early gastric cancer, tuberculosis, tuberculosis, pulmonary